Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics Munich, |
RCV000578248 | SCV000680257 | likely pathogenic | 3-hydroxyisobutyryl-CoA hydrolase deficiency | 2017-12-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002530365 | SCV003597976 | uncertain significance | Inborn genetic diseases | 2022-01-05 | criteria provided, single submitter | clinical testing | The c.830T>A (p.V277E) alteration is located in exon 11 (coding exon 11) of the HIBCH gene. This alteration results from a T to A substitution at nucleotide position 830, causing the valine (V) at amino acid position 277 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |